WallStreetZenWallStreetZen

NASDAQ: FRLN
Freeline Therapeutics Holdings PLC Stock

Open Broker Account
$0.77+0.08 (+11.59%)
Updated Sep 23, 2022
FRLN Price
$0.77
Fair Value Price
$3.42
Market Cap
$49.96M
52 Week Low
$0.65
52 Week High
$3.91
P/E
-0.28x
P/B
0.56x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$116.66M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.81
Operating Cash Flow
-$83M
Beta
0.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FRLN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FRLN ($0.77) is undervalued by 77.53% relative to our estimate of its Fair Value price of $3.42 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
FRLN ($0.77) is significantly undervalued by 77.53% relative to our estimate of its Fair Value price of $3.42 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
FRLN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FRLN due diligence checks available for Premium users.

Be the first to know about important FRLN news, forecast changes, insider trades & much more!

FRLN News

Valuation

FRLN fair value

Fair Value of FRLN stock based on Discounted Cash Flow (DCF)
Price
$0.77
Fair Value
$3.42
Undervalued by
77.50%
FRLN ($0.77) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FRLN ($0.77) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FRLN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

FRLN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.28x
Industry
15.88x
Market
27.65x

FRLN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.56x
Industry
4.31x
FRLN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

FRLN's financial health

Profit margin

Revenue
$0.0
Net Income
-$24.3M
Profit Margin
0%
FRLN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$162.1M
Liabilities
$72.5M
Debt to equity
0.81
FRLN's short-term assets ($96.11M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FRLN's short-term assets ($96.11M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FRLN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$16.6M
Investing
-$413.0k
Financing
$2.2M
FRLN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FRLN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FRLN$49.96M+11.94%-0.28x0.56x
NERV$49.82M+1.63%-1.01x-5.94x
MACK$49.62M-1.86%-30.83x3.64x
GLTO$50.79M+4.17%-0.84x0.60x
DYAI$48.89M-6.52%-4.10x3.60x

Freeline Therapeutics Holdings Stock FAQ

What is Freeline Therapeutics Holdings's quote symbol?

NASDAQ: FRLN) Freeline Therapeutics Holdings trades on the NASDAQ under the ticker symbol FRLN. Freeline Therapeutics Holdings stock quotes can also be displayed as NASDAQ: FRLN.

If you're new to stock investing, here's how to buy Freeline Therapeutics Holdings stock.

What is the 52 week high and low for Freeline Therapeutics Holdings (NASDAQ: FRLN)?

(NASDAQ: FRLN) Freeline Therapeutics Holdings's 52-week high was $3.91, and its 52-week low was $0.65. It is currently -80.33% from its 52-week high and 18.31% from its 52-week low.

How much is Freeline Therapeutics Holdings stock worth today?

(NASDAQ: FRLN) Freeline Therapeutics Holdings currently has 64,972,301 outstanding shares. With Freeline Therapeutics Holdings stock trading at $0.77 per share, the total value of Freeline Therapeutics Holdings stock (market capitalization) is $49.96M.

Freeline Therapeutics Holdings stock was originally listed at a price of $16.99 in Aug 13, 2020. If you had invested in Freeline Therapeutics Holdings stock at $16.99, your return over the last 2 years would have been -95.47%, for an annualized return of -78.73% (not including any dividends or dividend reinvestments).

How much is Freeline Therapeutics Holdings's stock price per share?

(NASDAQ: FRLN) Freeline Therapeutics Holdings stock price per share is $0.77 today (as of Sep 23, 2022).

What is Freeline Therapeutics Holdings's Market Cap?

(NASDAQ: FRLN) Freeline Therapeutics Holdings's market cap is $49.96M, as of Sep 27, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Freeline Therapeutics Holdings's market cap is calculated by multiplying FRLN's current stock price of $0.77 by FRLN's total outstanding shares of 64,972,301.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.